This IT is selectively cytotoxic in vitro in a dose-dependent manner for the CD19+ B-cell acute lymphoblastic leukemia cell line NALM-6, but it exhibits no toxicity for the CD19− T-ALL cell line HSB-2. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.